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Background: Although widely established in the management of malignant 
airway lesions, currently available tracheobronchial prostheses made of 
silicone have their drawbacks resulting from rigidity and wall thickness. 
Therefore we present clinical follow-up data obtained with a novel thin- 
walled expandable prototype silicone airway stent (Polyflex stent, Willy 
Riiseh AG, Kernen, Germany) in 19 patients. Methods: Seventeen of 19 
patients had tracheobronchial complications of infiltrating cancer: five had 
respiratory-digestive fistulas, 14 had mixed-type obstructions (mucosal 
infiltration plus extrinsic compression), and ta,~o had diffuse tracheal 
hemorrhages from the tumor surface (three patients had more than one 
complication). Two of 19 patients had benign postintubation stricture and 
malacia. Overall, 33 stents were implanted either simultaneously or in a 
consecutive manner. Scanning electron microscopy was performed both on 
prototype stents and on other available silicone stents for comparison. 
Results: The treatment improved the patients' clinical condition substan- 
tially. The mechanical properties of the new prosthesis were excellent. 
Important stent-associated si e effects were early mucus retention (n = 7), 
infolding of the inner silicone layer (n = 2), and stent dislodgment (n = 2). 
As of February 1997, 10 patients have died of causes unrelated to stent 
placement. Seven patients with malignant airway disease are still alive from 
2 weeks up to 7 months after initial treatment. Scanning electron micros- 
copy of explanted and unused prototypes uggested that an extremely 
ragged luminal microstructure may contribute to the firm adhesion of 
secretory material and that technical smoothing of the surface avoids such 
complications. Conclusions: The novel self-expandable silicone airway stent 
may be a promising addition to commonly used stent ypes. Short-term and 
medium-term anagement of fistulas, tumor surface bleeding, and stric- 
tures (malignant and benign) is satisfactory. Scanning electron microscopy 
of stents provides information on peculiar features of microstructure and 
material that may be of use in clinical research and technical innovation. 
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M alignant and benign stenoses of the central airways are a continuing challenge to the prac- 
ticing broncholaryngologist. Newly developed cylin- 
drical and bifurcated endoluminal silicone prosthe- 
ses have passed their clinical tests. They are 
currently being used to restore and maintain airway 
patency, with negligible side effects. Long-term re- 
sults are promising. 1-s However, because of their 
unfavorably low internal/external diameter ratio and 
their lack of flexibility, 4 they may impose an un- 
wanted resistance to air flow. In addition, tracheo- 
esophageal fistulas cannot be sealed and diffuse 
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Fig. 1. Polyflex prototype stents of variable lengths and diameters. 
mucosal bleeding unresponsive to laser treatment 
cannot be appropriately stopped by those devices. 
Bacterial adhesion to the stents sometimes poses 
serious long-term problems) We present prelimi- 
nary clinical follow-up data obtained with a novel 
thin-walled (0.45 ram) self-expanding cylindrical 
stent made of a texture of tightly woven polyester 
(TREVIRA)  filaments. The meshes are covered 
with a silicone layer. The prosthesis has an elastic 
recoil that enables it to regain the original shape 
after short-lived eforming events such as cough, 
forced expiration, and stent insertion itself, and to 
adapt smoothly to wall irregularities. Because the 
prosthesis is completely coated with silicone, tumor 
and granulation tissue should not grow through the 
meshes. The stent should seal the bronchial wall by 
intimate contact with the mucosa over its entire 
length (Fig. 1). 
Patients and methods 
Patients. From September 1995 to February 1997, 19 
patients have been treated. Seventeen of 19 patients had 
tracheobronchial complications of infiltrating cancer: five 
had respiratory-enteric fistulas (primary, n = 2; second- 
ary, n = 3), 14 had mixed-type obstructions, ~ and two had 
diffuse blood loss from the tumor surface. Three patients 
had more than one complicating condition. Two of 19 
patients had benign postintubation d sease: malacia below 
the cricoid in one and considerable tracheal restenosis 
caused by granulation tissue as a result of the insertion of 
a nitinol mesh wire stent in the other (Table I). 
Eight patients had relapsing tumor (esophageal carci- 
noma, n = 5; thyroid carcinoma, n = 1; lung carcinoma, 
n = 2) after resection and subsequent radiotherapy or 
chemotherapy or both. Three patients previously had 
other types of indwelling prostheses inserted into the 
central airways. All patients had unresectable tumors 
when first seen or, in the case of benign airway disease, a 
definitive operation was delayed. Stent placement was 
mandatory because of stridor or respiratory distress, he- 
moptysis, or clinical complaints consistent with tracheo- 
esophageal fistula. The patients gave informed consent. 
They were requested to undergo regular surveillance 
bronchoscopic examinations in our department every 2 
weeks. 
Operative techniques. With the patients under general 
anesthesia, orolaryngeal intubation was performed with 
the use of an operative laryngoscope attached to a chest 
support (Karl Storz, Tuttlingen, Germany). The tip of the 
laryngoscope had an internal diameter of 20 mm. It was 
positioned to expose the entire circumference of the vocal 
cords. Ventilation was sustained by a low-frequency oxy- 
gen jet hrough anozzle fixed at the proximal orifice of the 
instrument. The laryngoscope thus served as an access for 
necessary manipulations within the tracheobronchial tree, 
and at the same time it allowed continuous administration 
of oxygen. Before stent placement in patients with central 
obstruction, a set of semirigid plastic applicator tubes of 
increasing diameter were used to dilate the stenosis. In 
five of them, mechanical debulking with a rigid forceps 
preceded the bougie maneuver. During dilation, the jet 
was attached to he tube so that efficient ventilation could 
be maintained. The distal end of the applicator tube was 
extended just beyond the aboral edge of the stenosis. For 
verification of the tube's correct position, which has to be 
marked at the outside, bronchoscopic examination 
through the tube is indispensable. For insertion of the 
stent into the applicator, an open-ended flexible basket 
attached to the opposite tip of the pusher entraps the 
prosthesis, compressing it on its way into the narrow 
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Table  I. Patient characteristics and management (February 20, 1997) 
Total 
No. of 
Patient Nature of Reason for prototype Observations, side effects, 
(sex~age) lesion Site stenting stents complications Follow-up 
1 (M/56) Esophageal Ca Trachea Tumor bleeding 2 Retained secretions, bacterial 2 mo, death 
adhesions 
2 (M/63) Esophageal Ca Trachea Obstruction, sec- 6 Retained secretions, bacterial 10 mo, died of fatal 
ondary fistula adhesions, tumor overgrowth, hemorrhage 
infolding of silicone layer 
3 (M/57) Esophageal Ca Trachea Obstruction, sec- 2 Retained secretions, bacterial 11 mo, died of pneu- 
ondary fistula adhesions, tumor overgrowth monia 
4 (M/50) SCLC Trachea Obstruction 1 Retained secretions 2 too, died of meta- 
static disease 
5 (F/75) Thyroid Ca Trachea Obstruction 3 Retained secretions, tumor 1.5 mo, died of SVC 
overgrowth compression 
6 (M/45) Esophageal Ca Trachea Obstruction, sec- 1 9 too,* died of fatal 
ondary fistula hemorrhage 
7 (F/64) Esophageal Ca Trachea Primary fistula 2 Bacterial adhesions 1 mo, died of hepatic 
coma 
8 (M/71) NSCLC Trachea Obstruction l 1.5 too, alive 
9 (F/74) NSCLC Trachea Obstruction 1 2 too, alive 
!0 (M/53) Esophageal Ca Trachea Obstruction 1 Minor granulation tissue 1 mo, alive 
i l  (F/53) Esophageal Ca Trachea Obstruction 1 2 wk, alive 
!2 (M/51) NSCLC Left MB Obstruction 1 7 mo, alive 
!3 (M/75) NSCLC Right MB Obstruction 1 3 mo, alive 
14 (M/51) Esophageal Ca Right MB Primary fistula 1 Bacterial adhesions 2 too, died of pneu- 
monia 
!5 (M/75) NSCLC Right MB Obstruction 1 4 mo, alive 
16 (F/68) NSCLC Right MB Obstruction ! No complete reopening 1 mo, died of pneu- 
monia 
17 (F/57) NSCLC Right MB Obstruction 2 1.5 too, died of fatal 
hemorrhage 
t8 (F/72) Benign Trachea Malacia 2 Retained secretions, tent dis- Alive 
lodgment, bacterial adhesions, 
minor granulation tissue 
19 (M/37) Benign Trachea Stricture 3 Retained secretions, tent dis- Alive 
lodgment, minor granulation 
tissue, bacterial adhesions, 
infolding of silicone layer 
Ca, Carcinoma; SCLC, small-cell lung cancer; NSCLC, non-small-cell lung cancer; MB, main-stem bronchus; SVC, superior vena cava. 
*This patient was part of a previous study on the long-term effect of other common silicone stents. His death was probably due to endoscopic manipulation 
within a region of previous brachytherapy.l 
sheath (Fig. 2, A). After the stent has been inserted into 
the distal end of the tube, the basket is torn off with the 
stent in place. The applicator set plus indwelling pusher 
and stent is then guided to its premarked intratracheal or
intrabronchial position. After that, the tube is drawn back 
over the pusher, releasing the stent into the airway (Fig. 2, 
B). Bronchoscopic examination then confirms the correct 
position of the prosthesis. In cases of improper position- 
ing, the stent can be repositioned with the use of a rigid 
optical forceps. If necessary, atraumatic extraction 
through the relaxed vocal cords is performed with ease. 
Scanning electron mieroseopy (SEM). Five freshly ex- 
planted Polyflex stents (Willy Rfisch AG, Kernen, Ger- 
many) that had been in place 0.5, 1, 2, 3, and 10 months 
were placed in fixative (3% glutardialdehyde) overnight. 
Both the inner and outer surfaces were gently rinsed with 
phosphate-buffered saline solution (pH 7.4). Subse- 
quently, 1 cm 2 pieces were cut out and dehydrated 
through a series of ethanol dippings. Specimens were 
subjected to critical-point drying (Balzers CPD 020; Tech- 
notrade International, Inc. [Bal-Tec], Balzers, Liechten- 
stein) with carbon dioxide as the transitional fluid, 
mounted on scanning electron microscopy (SEM) stubs, 
gold coated (15 nm) in argon (Edwards Sputter Coater S 
150 B; Baxter Healthcare Corp., Edwards Division, Santa 
Aria, Calif.), and examined with a Nanolab 2000 SEM 
(Bausch & Lomb, Rochester, N.Y.). Samples of hitherto 
unused stents (Polyflex stent, n = 4; Dynamic stent, n = 2 
[Willy Rfisch], and Dumon, n = 2 [Bess Medizintechnik 
GmbH, Berlin, Germany]) were gold coated at once. 
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Fig. 2. A, Top, Stent, basket, and applicator sheath. Bottom, Introduction of stent into applicator by means 
of a basket. B, Top to bottom, Release of the stent into an obstructed airway segment. The tip of the 
operative laryngoscope is located at the vocal cord level. Inset, Details of stent release. See text for further 
information. 
Results 
Clinical results. To date we have implanted 33 
prototype stents of variable diameters and lengths 
into 19 patients (see Table I). The predominant 
location was the trachea. Two patients were pro- 
vided with two serial overlapping Polyflex stents 
each during the first intervention to seal a large 
bleeding tumor area or to reopen an unexpectedly 
long stenotic segment of the right main-stem and 
intermediate bronchi. In another two patients, in- 
dwelling Dumon prostheses were replaced by Poly- 
flex stents. In one the stent was used to decrease air 
flow resistance by a more favorable inner/outer 
diameter atio; in the other it was used to seal a 
tracheoesophageal fistula underneath the Dumon 
stent and at the same time bridge an obstruction 
located at the interface with an adjacent distal 
Dynamic stent. A rigid tracheal restenosis produced 
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Table II. Reasons for reintervention 
No. of events 
Reasons for stent exchange/extraction 
Dislodgment 3 
Tumor overgrowth 2 
Infolding of interior membrane 2 
Reasons for additional stent insertion 
Tumor overgrowth 3 
Fistula extension or insufficient seal 2 
Reasons for transient stenting 
Decompression byradiotherapy 1 
Stent-induced widening of benign stricture 1 
by granulation tissue that developed as a reaction to 
a nitinol mesh stent, inserted because of postintu- 
bation stricture, was dilated cautiously, and a Poly- 
flex stent was inserted to entirely cover the nitinol 
prosthesis (Fig. 3, A and B). 
An additional left-sided cordectomy was performed 
in a patient who had high-grade mixed obstruction of 
the proximal trachea nd complete bilateral vocal cord 
palsy. In another patient the right vocal cord was 
resected 5 months later, because of stridor, along with 
an intact functioning tracheal stent. 
Primary endoscopic treatment improved the pa- 
tients' clinical condition substantially. Tumor bleed- 
ing and hemoptysis were suppressed, fistulas were 
efficiently sealed for a certain time (14 days, 1, 1, 3, 
and 6 months), and satisfying tracheobronchial pa- 
tency could be achieved in all patients with benign 
disease and in all but one patients with malignant 
obstruction (see Table I). 
Supplemental overlapping stents were needed in 
four patients who had tumor overgrowth or exten- 
sion of fistula after 2 weeks (n = 2) and 1 month 
(n = 2). In three patients, two of whom had 
additional indwelling esophageal stents, secondary 
fistulas developed either spontaneously or after ra- 
diotherapy of infiltrating esophageal tumor under- 
neath a tracheal prosthesis 4 and 4.5 months after 
the initial intervention. Overgrowing tumor necessi- 
tated stent exchange in another patient after 2 
months. Continuing tumor growth and compression 
beyond the tracheal carina plus ostium of the main- 
stem bronchi n one patient required substitution of 
tracheal Polyflex stents by a bifurcated prosthesis 
(Dynamic stent) 1' 2 after 10 months. In two patients, 
the inner silicone layer of the prosthesis became 
detached from the filament meshwork and folded 
inside 1 and 3 months after initial treatment. These 
stents were replaced by new ones to prevent further 
luminal narrowing. Stent dislodgment occurred only 
Fig. 3. A, Patient 19. Tracheal stent covering granula- 
tion-induced stenosis. The passage from the proximal 
nonstented portion of the tracheal segment to the distal 
portion is step-shaped. The stent adapts smoothly to the 
narrowing airway lumen. B, Patient 3. Two overlapping 
serial stents in the trachea. 
in the benign cases and was the reason for three 
exchanges within 1 day to 1 month from previous 
treatment (Table II). 
A salient feature at follow-up bronchoscopic stud- 
ies was a gluelike sticky mucus inside the tracheal 
stents early in the postoperative course. It could be 
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Fig. 4. SEM. A, Prototype stent, outer surface. (Magnification 24.9×.) B, Piece of a torn and infolded 
membrane, outside. Rupture lines at the top of empty fiber channels (arrowheads). (Magnification 10.1×.) 
C, Early prototype stent, inner (luminal) surface, bird's eye view. (Magnification 249×.) D, Latest 
prototype stent, luminal surface. (Magnification 501×.) 
removed after being rinsed with saline solution and 
secretolytic agents using a bronchoscope with an 
extralarge working channel. Frequent inhalation of 
hypertonic saline solution did not entirely prevent 
the adhesion of slime within the stents, but it was 
easier to remove. However, mucus problems were 
encountered only in the early prototype tracheal 
stents. Such problems never occurred in the bron- 
chial prostheses that were derived from the same 
series or in any of the latest prototypes. Twelve of 
these prostheses were inserted into 11 patients ince 
September 1996. Pseudomonas aeruginosa, Staphylo- 
coccus aureus, and Escherichia coli were repeatedly 
isolated from the lavage specimens of seven pa- 
tients. As of February 1997, 10 patients have died. 
Causes of death were acute hemorrhage (n = 3), 
pneumonia (n = 3), hepatic oma (n = 1), respira- 
tory failure resulting from disseminated pulmonary 
metastases (n = 1), superior vena cava syndrome 
(n = 1), and unknown (n = 1). Seven patients with 
malignant tracheal obstruction are still alive from 2 
weeks up to 7 months after initial endoscopic treat- 
ment. Of the two patients with benign disease, one 
no longer has a stent. After removal of the proto- 
type, he had residual low-grade obstruction without 
clinical significance as evidenced by a minor de- 
crease of peak expiratory flow compared with the 
best flow rate before extraction (6.8 vs 7.3 L/sec). 
The other underwent tracheotomy and replacement 
of the frequently dislodged Polyflex stent by a 
Montgomery stent. 
SEM studies. Low-magnification SEM studies of 
the outside wall suggest hat the typical weaving 
texture of the polyester fibers makes the stents 
anchor on the mucosal surface (Fig. 4, A). Thin 
strata (4 to 10 /xm) of the otherwise large silicone 
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layer (450 ~m) span the outer vertex of the fila- 
ments, thus fixing the entire layer to the frame. 
Interestingly, it is through these strata that rupture 
lines of torn and infolded membranes run (Fig. 4, 
B). The inner surface of the early prototypes at low 
magnification (100 to 500×) and high magnification 
(1000× to 2000×) has an extremely ragged appear- 
ance (Fig. 4, C). A dense agglomeration of irregular 
lines, frequent jagged spikes about 50 ~m high, and 
sudden sharp brinks can be seen, as well as quite a 
few pores with orifices of up to 20 ~m in diameter. 
Cells and secretory material are occasionally found 
submerged in these pores. The respective features 
can be observed both in explanted and in hitherto 
unused stents. The improved latest prototypes show 
a flat, smooth inner surface (Fig. 4, D). Dumon and 
Dynamic stents 1were scanned for comparison. At 
low and high magnifications their luminal surfaces 
appear smooth and evenly structured by a delicate 
pattern of wavelike folds distributed in regular 
intervals over the whole area. No crude irregulari- 
ties or micropores can be observed. 
Discussion 
Although biomechanical studies are still unpub- 
lished, endoscopic evidence suggests that the cur- 
rently presented prototype is as resistant to extrinsic 
stress as are conventional silicone stents. The occur- 
rence of membrane infolding does not argue against 
these properties, because the supporting fiber frame 
remains stable. Kinking resulting from excessive 
compliance or even stent fracture was never ob- 
served. 
Unlike the other silicone-based prostheses that 
are inflexible because of massive circular coating, 
the new prototype readily adapts to uneven bron- 
chial contours uch as conical or step-shaped stric- 
tures. Thus stenting of complex obstructive pro- 
cesses is possible without excess luminal decrease or 
subsequent dislodgment. In addition, overlapping of 
sequential prototypes to extend the supported tra- 
cheobronchial segment without spatial interruption 
elegantly avoids exchange maneuvers that may end 
in fatal hemorrhage, as was reported after previous 
brachytherapy. 1 
Benign obstruction, in particular that resulting 
from malacia, certainly is difficult to stent with a 
cylindrical prosthesis. Dislodgment may occur either 
because of the stent's incomplete anchoring on a 
normal noninfiltrated mucosa or because of large 
differences in tracheal cross-sectional rea during 
inspiration and expiration associated with a low 
grade of radial expandability of the stent itself. 
Some authors have, however, documented restora- 
tion of long-standing patency in benign stenoses 
with the help of mesh wire wall stents. 5 
Airway stenting in tracheoesophageal or broncho- 
esophageal fistulas is not a common practice. How- 
ever, given that esophageal stents fail to obliterate 
fistulas in 33% to 70% of cases owing to the absence 
of tumor-associated stenosis, 6'7 a different approach 
may be necessary. Indeed, airway prostheses of the 
currently presented type are capable of sealing 
connections to the digestive tract on their own, as 
was the case in three of five patients. The remaining 
two patients had additional esophageal stents. Suf- 
ficient, albeit transient, closure of tracheoesopha- 
geal or bronchoesophageal fistulas was achieved for 
a median of 1 month before recurrence of symp- 
toms. This compares favorably with the 33.5 _+ 25.8 
days (mean _+ standard eviation) during which lone 
esophageal stents ustain intact function in patients 
who have a fistula. 8 Presumably, neither treatment 
will prolong mean survival over mere supportive 
care. 6 
For several reasons, the SEM technique was a 
valuable investigative tool to reveal biomaterial 
flaws underlying adverse clinical effects: 
1. The entire membrane is suspended on the 
meshwork by a thin, narrow layer of silicone span- 
ning the filaments. Dissection occurs exclusively 
within this layer, and infolding ensues. In other 
words, the most important area of the silicone stent 
would seem to be the weakest and most susceptible 
to shearing stress. Therefore a more intimate weld 
of filament and silicone or else a thicker outside 
layer should prevent its being torn off. 
2. The observed features of the internal surface 
may have precipitated frequent episodes of mucus 
plugging. In view of the ragged appearance, it is 
conceivable that slime and cellular debris were 
caught in place mechanically. Additional factors 
may have been both a decrease in humidity in holes 
and pits, with secondary rapid drying out, and 
cellular adherence to the biomaterial. 9 
We therefore hypothesize that properties of the 
surface microstructure may lead to rapid adhesion 
of secretory particles and that, on the other hand, 
modification of the surface might substantially im- 
prove the issue. We scanned Dumon and Dynamic 
stents in parallel and found only smooth surfaces, 
with a delicate texture of regular wrinkles at com- 
parable magnifications. The fact that mucus impac- 
tion in these two types of stents is reportedly 1' 3 rare 
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is indirect evidence in favor of our hypothesis. In 
addition, we did not observe problems with retained 
mucus with the latest improved stent types. 
3. Given the frequent and repetitive culture of 
Staphylococcus aureus and Pseudomonas eruginosa, s 
well as other gram negative strains, from respiratory 
secretions of patients with stents, concern has been 
raised over the clinical impact of chronic purulent 
bronchitis associated with silicone airway prostheses. 1 
It was speculated that microbes might be able to 
damage and colonize the plastic substance, thus facil- 
itating bacterial adhesion and subsequent chronic in- 
flammation. 1 However, no signs suggestive of "biode- 
terioration ''1° could be found on SEM scrutiny, 
because the observed features were invariably present 
in explanted and unused stents alike. It is therefore 
possible that bacteria dhere to the devices, using the 
preformed irregular landscape. In vitro studies to 
quantify bacterial adherence on different stent types 
and materials are ongoing. 
In conclusion, the mechanical properties of the 
new self-expandable silicone stent make it a future 
candidate to restore and sustain patency in malig- 
nant central airway stenoses. The spectrum of indi- 
cations for silicone stents may be enlarged to involve 
the transient seal of respiratory-enteric fistulas and 
diffuse mucosal bleeding. 
However, drawbacks remain: Occasional infold- 
ing of the interior membrane may lead to secondary 
obstruction. Owing to its peculiar microstructure, 
the new prototype tends to retain mucus early after 
implantation. Bacterial adhesion is a property 
shared by the other commonly available silicone 
stents. Frequent dislodgment in benign stenosis as a 
result of malacia appears to disqualify the stent for 
this indication. 
The SEM technique provides useful information 
on surface profiles, flaws, and potential changes of 
stent material before placement and after long- 
standing tissue exposure. SEM follow-up as a basis 
for eventual technical improvements should help to 
prevent untoward effects of indwelling prostheses. 
Before final recommendations can be given, long- 
term observations are warranted. 
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